JHS SVENDGAARD LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of JHS SVENDGAARD LABORATORIES have decreased by -16.53% YoY .
The Earnings Per Share (EPS) of JHS SVENDGAARD LABORATORIES has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
JHS SVENDGAARD LABORATORIES Last 5 Annual Financial Results
[BOM: 532771|NSE : JHS]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹71 Cr | ₹85 Cr | ₹86 Cr | ₹101 Cr | ₹139 Cr |
| Expenses | ₹72 Cr | ₹94 Cr | ₹87 Cr | ₹99 Cr | ₹137 Cr |
| Operating Profit (Excl OI) | ₹-0.94 Cr | ₹-9.07 Cr | ₹-0.84 Cr | ₹1.92 Cr | ₹1.67 Cr |
| Other Income | ₹4.31 Cr | ₹11 Cr | ₹9.39 Cr | ₹7.54 Cr | ₹14 Cr |
| Interest | ₹0.46 Cr | ₹0.55 Cr | ₹1.39 Cr | ₹1.24 Cr | ₹1.95 Cr |
| Depreciation | ₹6.35 Cr | ₹6.02 Cr | ₹7.05 Cr | ₹7.26 Cr | ₹8.76 Cr |
| Profit Before Tax | ₹-3.43 Cr | ₹-23 Cr | ₹0.10 Cr | ₹0.97 Cr | ₹-5.84 Cr |
| Profit After Tax | ₹-4.06 Cr | ₹-18 Cr | ₹-4.29 Cr | ₹1.34 Cr | ₹-4.86 Cr |
| Consolidated Net Profit | ₹-4.06 Cr | ₹-17 Cr | ₹-4.05 Cr | ₹1.20 Cr | ₹-1.98 Cr |
| Earnings Per Share (Rs) | ₹-2.31 | ₹-0.52 | ₹-2.20 | ₹-0.62 | ₹0.19 |
| PAT Margin (%) | -21.46 | -5.73 | -20.65 | -4.97 | 1.33 |
| ROE(%) | -11.61 | -2.36 | -9.75 | -2.36 | 0.76 |
| ROCE(%) | -6.80 | -1.71 | -12.43 | 0.82 | 1.24 |
| Total Debt/Equity(x) | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 106.9 Cr |
| Revenue (TTM) | : | ₹ 91.0 Cr |
| Net Profit(TTM) | : | ₹ -18.1 Cr |
| EPS (TTM) | : | ₹ -2.1 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JHS SVENDGAARD LABORATORIES | -4.7% | 7.1% | -51.6% |
| HINDUSTAN UNILEVER | -1.4% | -4.2% | -3.2% |
| GODREJ CONSUMER PRODUCTS | 3% | -0.1% | -9.3% |
| DABUR INDIA | 4.5% | 6.1% | -4.3% |
| COLGATEPALMOLIVE (INDIA) | -3.7% | -2.5% | -28.4% |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | -1.3% | -8% | -16.9% |
| GILLETTE INDIA | -4.3% | -7.5% | -12.7% |
| EMAMI | -3.5% | -6.1% | -23.5% |
| CELLO WORLD | -2.3% | 10.6% | -23.1% |
JHS SVENDGAARD LABORATORIES Revenues
[BOM: 532771|NSE : JHS]
| Y-o-Y | -16.53 % |
| 5 Yr CAGR | -15.54 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹71 Cr | -16.53 | |
| Mar2024 | ₹85 Cr | -1.67 | |
| Mar2023 | ₹86 Cr | -14.40 | |
| Mar2022 | ₹101 Cr | -27.57 | |
| Mar2021 | ₹139 Cr | - | |
JHS SVENDGAARD LABORATORIES Operating Profit
[BOM: 532771|NSE : JHS]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.94 Cr | Negative | |
| Mar2024 | ₹-9.07 Cr | Negative | |
| Mar2023 | ₹-0.84 Cr | Negative | |
| Mar2022 | ₹1.92 Cr | 14.71 | |
| Mar2021 | ₹1.67 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | -1.32% | Negative | |
| Mar2024 | -10.7% | Negative | |
| Mar2023 | -0.98% | Negative | |
| Mar2022 | 1.9% | 58.33 | |
| Mar2021 | 1.2% | - | |
JHS SVENDGAARD LABORATORIES Profit After Tax
[BOM: 532771|NSE : JHS]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.06 Cr | Negative | |
| Mar2024 | ₹-17 Cr | Negative | |
| Mar2023 | ₹-4.05 Cr | Negative | |
| Mar2022 | ₹1.20 Cr | Positive | |
| Mar2021 | ₹-1.98 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | -21.46 % | Negative | |
| Mar2024 | -5.73 % | Negative | |
| Mar2023 | -20.65 % | Negative | |
| Mar2022 | -4.97 % | Negative | |
| Mar2021 | 1.33 % | - | |
JHS SVENDGAARD LABORATORIES Earnings Per Share (EPS)
[BOM: 532771|NSE : JHS]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.31 | Negative | |
| Mar2024 | ₹-0.52 | Negative | |
| Mar2023 | ₹-2.20 | Negative | |
| Mar2022 | ₹-0.62 | Negative | |
| Mar2021 | ₹0.19 | - | |
JHS SVENDGAARD LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532771|NSE : JHS]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | -6.8% | Negative | |
| Mar2024 | -1.71% | Negative | |
| Mar2023 | -12.43% | Negative | |
| Mar2022 | 0.82% | -33.87 | |
| Mar2021 | 1.24% | - | |
JHS SVENDGAARD LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹12.5 |
| Current MarketCap | : | ₹ 106.9 Cr |
| Updated EOD on | : | Nov 06,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JHS SVENDGAARD LABORATORIES | -4.7% |
7.1% |
-51.6% |
| SENSEX | -2% |
2.6% |
4.2% |
JHS SVENDGAARD LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about JHS SVENDGAARD LABORATORIES Financials
How the annual revenues of JHS SVENDGAARD LABORATORIES have changed ?
The Revenues of JHS SVENDGAARD LABORATORIES have decreased by -16.53% YoY .
How the Earnings per Share (EPS) of JHS SVENDGAARD LABORATORIES have changed?
The Earnings Per Share (EPS) of JHS SVENDGAARD LABORATORIES has decreased by Negative YoY .
Check out Intrinsic Value of Peers of JHS SVENDGAARD LABORATORIES
Compare Stock Analytics of Peers of JHS SVENDGAARD LABORATORIES
HINDUSTAN UNILEVER LTD vs GODREJ CONSUMER PRODUCTS LTD vs DABUR INDIA LTD
COLGATEPALMOLIVE (INDIA) LTD vs PROCTER & GAMBLE HYGIENE AND HEALTH CARE LTD vs
HINDUSTAN UNILEVER LTD vs GODREJ CONSUMER PRODUCTS LTD vs DABUR INDIA LTD
COLGATEPALMOLIVE (INDIA) LTD vs PROCTER & GAMBLE HYGIENE AND HEALTH CARE LTD vs
